Cargando…

Predicting the requirement for renal replacement therapy in intensive care patients with sepsis

Detalles Bibliográficos
Autores principales:	Nierhaus, Axel, Bloos, Frank, Wilson, Darius Cameron, Elke, Gunnar, Meybohm, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100710/ https://www.ncbi.nlm.nih.gov/pubmed/30122149 http://dx.doi.org/10.1186/s13054-018-2135-5

Ejemplares similares

Identification of developing multiple organ failure in sepsis patients with low or moderate SOFA scores
por: Elke, Gunnar, et al.
Publicado: (2018)

The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial
por: Elke, Gunnar, et al.
Publicado: (2018)

The prevalence of sepsis-induced coagulopathy in patients with sepsis – a secondary analysis of two German multicenter randomized controlled trials
por: Schmoch, Thomas, et al.
Publicado: (2023)

Adrenomedullin in COVID-19 induced endotheliitis
por: Wilson, Darius Cameron, et al.
Publicado: (2020)

Anticoagulation in COVID-19 patients requiring continuous renal replacement therapy
por: Attallah, Nizar, et al.
Publicado: (2021)

Presepsin and sepsis-induced acute kidney injury treated with continuous renal replacement therapy: will another promising biomarker bite the dust?
por: Honore, Patrick M., et al.
Publicado: (2015)

Epidemiology and outcomes of elderly patients requiring renal replacement therapy in the intensive care unit: an observational study
por: Salathé, Cécile, et al.
Publicado: (2021)

Rapid diagnosis of sepsis
por: Bloos, Frank, et al.
Publicado: (2014)

The furosemide stress test to predict renal function after continuous renal replacement therapy
por: van der Voort, Peter HJ, et al.
Publicado: (2014)

Prediction of renal recovery following sepsis-associated acute kidney injury requiring renal replacement therapy using contrast-enhanced ultrasonography
por: Shin, Jungho, et al.
Publicado: (2023)

Use of Intravenous Immunoglobulins in Sepsis Therapy—A Clinical View
por: Jarczak, Dominik, et al.
Publicado: (2020)

Continuous renal replacement and removal of inflammatory mediators in sepsis: Still an open debate
por: Buonanno, Pasquale, et al.
Publicado: (2021)

Early sepsis identification following cytoreductive surgery for peritoneal malignancy
por: Wilson, Darius Cameron, et al.
Publicado: (2020)

Sepsis—Pathophysiology and Therapeutic Concepts
por: Jarczak, Dominik, et al.
Publicado: (2021)

Adsorption and caspofungin dosing during continuous renal replacement therapy
por: Honore, Patrick M., et al.
Publicado: (2019)

Biomarkers Predicting Survival of Sepsis Patients Treated with Continuous Renal Replacement Therapy
por: Lee, Jeong Ho, et al.
Publicado: (2017)

Proenkephalin Predicts Organ Failure, Renal Replacement Therapy, and Mortality in Patients With Sepsis
por: Kim, Hanah, et al.
Publicado: (2020)

Neutrophil gelatinase-associated lipocalin elimination by renal replacement therapy: minding the membrane!
por: Honore, Patrick M., et al.
Publicado: (2016)

‘Biomarking’ infection during continuous renal replacement therapy: still relevant?
por: Honore, Patrick M, et al.
Publicado: (2015)

Intertwining extracorporeal membrane oxygenation and continuous renal replacement therapy: sense or nonsense?
por: Jacobs, Rita, et al.
Publicado: (2015)

Filter survival time and requirement of blood products in patients with severe sepsis receiving drotrecogin alfa (activated) and requiring renal replacement therapy
por: Camporota, Luigi, et al.
Publicado: (2008)

Biomarkers and clinical scores to aid the identification of disease severity and intensive care requirement following activation of an in-hospital sepsis code
por: Baldirà, Jaume, et al.
Publicado: (2020)

Does renal replacement therapy increase mortality in the ICU?
por: Pestaña, David
Publicado: (2011)

Timing of renal replacement therapy: is it when or how much?
por: Mahadeshwar, Teja, et al.
Publicado: (2013)

Sepsis: Diagnostic and Therapeutic Challenges
por: Molnár, Zsolt, et al.
Publicado: (2016)

qSOFA should replace SIRS as the screening tool for sepsis
por: Franchini, Stefano, et al.
Publicado: (2016)

Laboratory prediction of the requirement for renal replacement in acute falciparum malaria
por: Hanson, Josh, et al.
Publicado: (2011)

Renal replacement therapy in the intensive care unit
por: Pannu, Neesh, et al.
Publicado: (2005)

Renal replacement therapy in the intensive care unit
por: Chacko, Jose
Publicado: (2008)

Endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker?
por: Honore, Patrick M., et al.
Publicado: (2019)

Higher colistin dose during continuous renal replacement therapy: look before leaping!
por: Honore, Patrick M., et al.
Publicado: (2015)

No dose adjustment of tigecycline is necessary during continuous renal replacement therapy: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020)

Some metabolic issues should not be neglected when using citrate for continuous renal replacement therapy!
por: Jacobs, Rita, et al.
Publicado: (2015)

Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
por: Honore, Patrick M., et al.
Publicado: (2019)

To Compare Acute Peritoneal Dialysis with Sustained Low-efficiency Dialysis in Critically Ill Patients Requiring Renal Replacement Therapy
por: Datt, B., et al.
Publicado: (2017)

Acute renal failure in patients with sepsis
por: Lopes, José António, et al.
Publicado: (2007)

Heparin algorithm for anticoagulation during continuous renal replacement therapy
por: Ostermann, Marlies, et al.
Publicado: (2010)

Survival in children requiring chronic renal replacement therapy
por: Chesnaye, Nicholas C., et al.
Publicado: (2017)

Continuous renal replacement therapy for safe and adequate voriconazole intravenous treatment: enough reason to be confident?
por: Honore, Patrick M, et al.
Publicado: (2015)

Is neutrophil gelatinase-associated lipocalin unaffected by convective continuous renal replacement therapy? Definitely … maybe
por: Honore, Patrick M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2htc3it2ct8m1i7dc21313i7c4